City

Columbus (1)

Jonesboro (1)

Tampa (1)

Condition

Adenocarcinomas of the Gastroesophageal Junction (3)

Adenocarcinoma of the Distal Esophagus (1)

Adenocarcinoma of the Esophagus (1)

Adenocarcinoma of the Proximal Stomach (1)

Esophageal Adenocarcinomas (1)

Gastroesophageal Adenocarcinoma (1)

Recurrent Esophageal Cancer (1)

Squamous Cell Carcinoma of the Esophagus (1)

Stage IV Esophageal Cancer (1)

Overall Status

Terminated (2)

Completed (1)

Phase

phase 2 (3)

Sponsor

Accelerated Community Oncology Research Network (1)

H. Lee Moffitt Cancer Center and Research Institute (1)

Ohio State University Comprehensive Cancer Center (1)

Collaborator

Amgen (1)

Aventis Pharmaceuticals (1)

National Comprehensive Cancer Network (1)

Spectrum Pharmaceuticals, Inc (1)

Study Documents

Intervention Type

drug (3)

procedure (2)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

adenocarcinomas of the gastroesophageal junction

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adenocarcinoma of the Esophagus, Adenocarcinomas of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in Columbus

Completed

Has Results

Adenocarcinoma of the Esophagus
+4 more

pralatrexate
+3 more

Columbus, Ohio

Ohio State University

Apr 25, 2016

Esophageal Adenocarcinomas, Adenocarcinomas of the Gastroesophageal Junction Trial in Tampa (docetaxel, cisplatin, radiation)

Terminated

Esophageal Adenocarcinomas
Adenocarcinomas of the Gastroesophageal Junction

docetaxel
+3 more

Tampa, Florida

H. Lee Moffitt Cancer Center & Research Institute

Nov 21, 2013

Gastroesophageal Adenocarcinoma, Adenocarcinoma of the Distal Esophagus, Adenocarcinomas of the Gastroesophageal Junction Trial

Terminated

Has Results

Gastroesophageal Adenocarcinoma
+3 more

Panitumumab
+3 more

Jonesboro, Arkansas

Clopton Clinic

Nov 29, 2012